Afficher la notice abrégée

dc.contributor.authorSukul, Abhijit
dc.contributor.authorHaque, Sanjana
dc.contributor.authorHasan, Md. Mehdi
dc.contributor.authorUddin, Farid
dc.date.accessioned2016-12-31T07:04:53Z
dc.date.available2016-12-31T07:04:53Z
dc.date.issued2016
dc.identifier.citationSukul, Abhijit; Haque, Sanjana; Hasan, Md. Mehdi & Uddin, Farid (2016). Ebola virus pathogenesis: implications for diagnosis and prevention, International Journal of Pharmacology & Toxicology.6(2), 74-81.en_US
dc.identifier.issn2249-7668 (Online)
dc.identifier.issn2249-7676 (Print)
dc.identifier.urihttp://hdl.handle.net/123456789/1017
dc.description.abstractEbola virus disease (EVD) declared as “one of the world‟s most virulent diseases” by WHO was popularly known as Ebola haemorrhagic fever in the past which is usually considered a severe and deadly illness when humans are concerned. It can caused by a virus of the Filoviridae family (genus Ebolavirus) and spreads by human to human transmission through contacts with body fluids from infected patients. Common symptoms include fever, profound weakness, diarrhea, abdominal pain, cramping, nausea and vomiting for 3-5 days and maybe persisting for up to a week. Laboratory complications like elevated aminotransferase levels, marked lymphocytopenia, and thrombocytopenia may have occurred. The symptoms progress over the time and patients suffer from various types of diseases like dehydration, stupor, confusion, hypotension, multi-organ failure, leading to fulminant shock and eventually death. Others characteristics of Ebola virus infections are suppression of immune response and a systemic inflammatory response, which further causes impairment of the vascular, coagulation, and immune systems. It can be diagnosed by enzyme -linked immuno-sorbent assay (ELISA), antigen detection tests, serum neutralization test, reverse transcription polymerase chain reaction (RT -PCR) assay, virus isolation by cell culture. Based on above mentioned, the present article aimed to review the pathophysiology, transmission, clinical manifestation, diagnosis, treatment, and prevention of Ebola virus diseaseen_US
dc.language.isoenen_US
dc.publisherInternational Journal of Pharmacology & Toxicologyen_US
dc.subjectEVD, Risk, Pathophysiologyen_US
dc.titleEbola virus pathogenesis: implications for diagnosis and preventionen_US
dc.typeArticleen_US


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée